Mark E. Bertels - 10 Jun 2024 Form 4 Insider Report for CORVEL CORP (CRVL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Jun 2024, 15:54:46 UTC
Prior SEC filing
21 May 2024
Next SEC filing
13 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Sharon O'Connor For: Mark Bertels

Key filing fact

Mark E. Bertels filed Form 4 for CORVEL CORP (CRVL) on 12 Jun 2024.

Key facts

  • This page summarizes Mark E. Bertels's Form 4 filing for CORVEL CORP (CRVL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Jun 2024, 15:54.

Change

  • Previous filing in this sequence was filed on 21 May 2024.
  • Current net transaction value: -$28,730.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL transaction

Common Stock

Options Exercise

Transaction value
$17,498
Shares
+200
Change %
+23%
Price
$87.49
Shares after
1,058
Date
10 Jun 2024
Ownership
Direct
CRVL transaction

Common Stock

Sale

Transaction value
$46,228
Shares
-200
Change %
-19%
Price
$231.14
Shares after
858
Date
10 Jun 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-200
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200
Exercise price
$87.49
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .